Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Boehm, Franziska ^a   Martin, Maria ^a   Kesselring, Rebecca ^a   Schiechl, Gabriela ^a   Geissler, Edward K ^a   Schlitt, Hans Jürgen ^a   Fichtner Feigl, Stefan ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; DOCUSATE SODIUM; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE SEVERITY; ENTERITIS; INTESTINE MUCOSA; LIVER; LUNG; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; WEIGHT REDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLITIS; CYTOKINES; DEXTRAN SULFATE; DIPHTHERIA TOXIN; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PNEUMONIA; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 84864330113     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-97     Document Type: Article

References (43)

1. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009, 30:616-625. 10.1016/j.immuni.2009.04.009, 19464984.
2. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007, 8:191-197. 10.1038/ni1428, 17136045.
3. Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, deRoos P, Rudensky A, Sparwasser T. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 2009, 183:7631-7634. 10.4049/jimmunol.0804308, 19923467.
4. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003, 4:330-336.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061. 10.1126/science.1079490, 12522256.
6. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003, 4:337-342.
7. Fontenot JD, Rasmussen JP, Williams LM, dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341. 10.1016/j.immuni.2005.01.016, 15780990.
8. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001, 27:68-73.
9. Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002, 39:537-545. 10.1136/jmg.39.8.537, 1735203, 12161590.
10. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009, 30:636-645. 10.1016/j.immuni.2009.04.010, 19464986.
11. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003, 3:521-533. 10.1038/nri1132, 12876555.
12. Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006, 212:256-271. 10.1111/j.0105-2896.2006.00423.x, 16903919.
13. Izcue A, Coombes JL, Powrie F. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 2009, 27:313-338. 10.1146/annurev.immunol.021908.132657, 19302043.
14. Izcue A, Powrie F. Special regulatory T-cell review: Regulatory T cells and the intestinal tract-patrolling the frontier. Immunology 2008, 123:6-10. 10.1111/j.1365-2567.2007.02778.x, 2433286, 18154611.
15. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005, 204:184-194. 10.1111/j.0105-2896.2005.00250.x, 15790359.
16. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999, 117:1078-1088. 10.1016/S0016-5085(99)70392-6, 10535870.
17. Powrie F, Read S, Mottet C, Uhlig H, Maloy K. Control of immune pathology by regulatory T cells. Novartis Found Symp 2003, 252:92-98. discussion 98-105, 106-14.
18. Read S, Powrie F. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Curr Protoc Immunol 2001, : . Chapter 15:Unit 15 13.
19. Singh B, Read S, Asseman C, Malmstrom V, Mottet C, Stephens LA, Stepankova R, Tlaskalova H, Powrie F. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001, 182:190-200. 10.1034/j.1600-065X.2001.1820115.x, 11722634.
20. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008, 8:411-420. 10.1038/nri2316, 18469830.
21. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009, 31:401-411. 10.1016/j.immuni.2009.08.011, 19766083.
22. Boden EK, Snapper SB. Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol 2008, 24:733-741. 10.1097/MOG.0b013e328311f26e, 19125486.
23. Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006, 177:5852-5860.
24. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, Stallmach A, Zeitz M, Duchmann R. Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005, 128:1868-1878. 10.1053/j.gastro.2005.03.043, 15940622.
25. Holmen N, Lundgren A, Lundin S, Bergin AM, Rudin A, Sjovall H, Ohman L. Functional CD4+CD25 high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis 2006, 12:447-456. 10.1097/00054725-200606000-00003, 16775488.
26. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 2010, 30:80-89. 10.1007/s10875-009-9345-1, 19936899.
27. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, Nakamura T, Koganei K, Fukushima T, Watanabe M. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004, 173:3119-3130.
28. Sitohy B, Hammarstrom S, Danielsson A, Hammarstrom ML. Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action. Clin Exp Immunol 2008, 151:326-333. 10.1111/j.1365-2249.2007.03566.x, 2276944, 18190460.
29. Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 2007, 13:191-199. 10.1002/ibd.20053, 17206665.
30. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 2009, 21:281-285. 10.1016/j.coi.2009.05.007, 2733784, 19500966.
31. Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martinez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009, 10:1000-1007. 10.1038/ni.1774, 2729804, 19633673.
32. Saruta M, Yu QT, Fleshner PR, Mantel PY, Schmidt-Weber CB, Banham AH, Papadakis KA. Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease. Clin Immunol 2007, 125:281-290. 10.1016/j.clim.2007.08.003, 17897887.
33. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE. TNF down modulates the function of human CD4+CD25hi T-regulatory cells. Blood 2006, 108:253-261. 10.1182/blood-2005-11-4567, 1895836, 16537805.
34. Nadkarni S, Mauri C, Ehrenstein MR. Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 2007, 204:33-39. 10.1084/jem.20061531, 2118431, 17200409.
35. Ricciardelli I, Lindley KJ, Londei M, Quaratino S. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease. Immunology 2008, 125:178-183. 10.1111/j.1365-2567.2008.02839.x, 2561134, 18422560.
36. Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A, Vitolo D, Boirivant M. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis 2008, 14:662-668. 10.1002/ibd.20369, 18240282.
37. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolaed L, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463. 10.1126/science.1135245, 17068223.
38. Hue S, Ahern P, Buonocore S, Kullberg MC, Cuad J, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006, 203:2473-2483. 10.1084/jem.20061099, 2118132, 17030949.
39. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370. 10.1053/j.gastro.2007.03.104, 17570211.
40. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cuad J, Powrie F, Cheever AW, Maloy KJ, Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006, 203:2485-2494. 10.1084/jem.20061082, 2118119, 17030948.
41. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cuad J, Powrie F. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318. 10.1016/j.immuni.2006.05.017, 16919486.
42. Izcue A, Hue S, Buonocore S, Arancibia-Carcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008, 28:559-570. 10.1016/j.immuni.2008.02.019, 2292821, 18400195.
43. Liu G, Zhao Y. Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells. Immunology 2007, 122:149-156. 10.1111/j.1365-2567.2007.02651.x, 2266004, 17848162.